TELA Bio logo
TELA Bio TELA
$ 2.94 1.21%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

TELA Bio Income Statement 2011-2024 | TELA

Annual Income Statement TELA Bio

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

131 M 164 M 177 M 185 M 26.1 M - - - - - - - -

Shares

22.9 M 16.3 M 14.5 M 12.9 M 1.77 M - - - - - - - -

Historical Prices

5.73 10.1 12.2 14.3 14.9 - - - - - - - -

Net Income

-46.7 M -44.3 M -33.3 M -28.8 M -22.4 M -21.1 M -21.3 M - - - - - -

Revenue

58.5 M 41.4 M 29.5 M 18.2 M 15.4 M 8.27 M 4.24 M - - - - - -

Cost of Revenue

18 M 13.6 M 10.3 M 6.68 M 5.87 M 4.55 M 1.71 M - - - - - -

Gross Profit

40.1 M 27 M 18.8 M 11.2 M 9.27 M 2.94 M 2.53 M - - - - - -

Operating Income

-44.1 M -39 M -29.5 M -25.3 M -19.2 M -17.8 M -16.9 M - - - - - -

Interest Expense

5.22 M 4.05 M 3.6 M 3.56 M 3.61 M 1.8 M 4.56 M - - - - - -

EBITDA

-43.6 M -38.6 M -29.2 M -25.1 M -18.6 M -18.7 M -16.2 M - - - - - -

Operating Expenses

84.2 M 66.1 M 48.3 M 36.5 M 28.4 M 22.9 M 19.5 M - - - - - -

General and Administrative Expenses

14.9 M 13.9 M 12.5 M 10.1 M 6.22 M 4.9 M 4.96 M - - - - - -

All numbers in USD currency

Quarterly Income Statement TELA Bio

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

24.7 M 24.7 M 24.5 M 24.5 M 23.2 M 19.2 M 19.2 M 16.8 M 14.6 M 14.5 M 14.5 M 14.5 M 14.5 M 14.4 M 14.4 M 14.4 M 11.4 M 11.4 M 11.4 M 298 K 296 K 296 K 296 K 295 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-10.4 M -12.6 M - -11 M -10.8 M -12 M - -10.7 M -12.7 M -10.9 M - -8.27 M -8.26 M -8.14 M - -7.7 M -6.08 M -7.22 M - -4.67 M -5.26 M -5.97 M - -2.81 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

19 M 16.1 M - 15.1 M 14.5 M 11.9 M - 11.2 M 10.4 M 8.23 M - 7.65 M 7.56 M 5.88 M - 5.31 M 3.51 M 3.73 M - 3.97 M 3.3 M 3.31 M - 2.21 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

6 M 4.92 M - 4.57 M 4.2 M 3.92 M - 3.74 M 3.32 M 3.16 M - 2.98 M 2.4 M 2.34 M - 1.95 M 1.35 M 1.45 M - 1.29 M 1.32 M 1.43 M - 769 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

12.9 M 11.1 M - 10.4 M 10.2 M 7.9 M - 7.32 M 6.55 M 5 M - 4.6 M 5.09 M 3.46 M - 3.29 M 2.08 M 2.2 M - 2.6 M 1.91 M 1.8 M - 1.37 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-9.36 M -11.6 M - -10.2 M -10.4 M -11.3 M - -9.49 M -10.2 M -9.84 M - -7.22 M -7.31 M -7.27 M - -6.86 M -5.17 M -6.5 M - -3.86 M -4.3 M -5.18 M - -2.52 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

337 K 301 K - 558 K 870 K 1.25 M - 1.03 M 934 K 911 K - 922 K 864 K 889 K - 898 K 884 K 879 K - 899 K 914 K 912 K - 309 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - -11.1 M - -9.22 M -10.1 M -9.77 M - -7.05 M -7.19 M -7.2 M - -6.7 M -5.07 M -6.44 M - -3.65 M -4.16 M -5.11 M - -2.13 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

22.2 M 22.6 M - 20.6 M 20.6 M 19.2 M - 16.8 M 16.8 M 14.8 M - 11.8 M 12.4 M 10.7 M - 10.2 M 7.25 M 8.7 M - 6.46 M 6.21 M 6.98 M - 3.89 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

3.68 M 3.62 M - 3.73 M 3.47 M 3.63 M - 3.53 M 3.63 M 3.46 M - 3.46 M 2.97 M 2.76 M - 2.61 M 2.15 M 2.52 M - 1.21 M 1.2 M 1.32 M - 1.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency